» Authors » Jonathan A Bernstein

Jonathan A Bernstein

Explore the profile of Jonathan A Bernstein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 572
Citations 12167
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Aygoren-Pursun E, Magerl M, Craig T, Manning M, Hummel N, et al.
Allergy Asthma Clin Immunol . 2025 Mar; 21(1):10. PMID: 40089800
Background: The goal of on-demand treatment for hereditary angioedema attacks is to halt attack progression to minimize morbidity and mortality. Four on-demand treatments have been approved thus far (ecallantide, icatibant,...
2.
Christiansen S, Banerji A, Bernstein J, Busse P, Craig T, Li H, et al.
J Allergy Clin Immunol Pract . 2025 Mar; PMID: 40057189
Hereditary angioedema with normal C1 inhibitor (HAE-nl-C1INH) was initially described almost a quarter century ago. Considerable progress towards unraveling the mysteries of this complex disease has been made during the...
3.
Louvrier C, Desroziers T, Soreze Y, Delgado Rodriguez M, Thomas L, Nau V, et al.
EBioMedicine . 2025 Mar; 113:105626. PMID: 40023045
Background: LAMP3 encodes a lysosomal membrane protein associated with lamellar bodies and has recently been proposed as a candidate gene for childhood interstitial lung diseases (chILD). Here, we identified two...
4.
Weller K, Winders T, McCarthy J, Raftery T, Saraswat P, Constantinescu C, et al.
Dermatol Ther (Heidelb) . 2025 Feb; 15(3):747-761. PMID: 40019716
Introduction: The impact of chronic spontaneous urticaria (CSU) on patients' health-related quality of life (HRQoL) is well documented. However, considerable gaps remain in understanding the experience, perception and needs of...
5.
Workman B, Nabors L, Pierre Hixon D, Merianos A, Odar Stough C, Bernstein J, et al.
Children (Basel) . 2025 Feb; 12(2). PMID: 40003335
Background/objectives: This study assesses parent reports of adolescent- and parent-level factors related to friendships among adolescents with asthma. This study serves to inform physicians and other health care professionals of...
6.
McLaren J, Chon Y, Gorski K, Bernstein J, Corren J, Hayama K, et al.
J Allergy Clin Immunol . 2025 Feb; PMID: 39956278
Background: Tezepelumab, an mAb inhibiting thymic stromal lymphopoietin, is an upstream-targeted therapy with potential to inhibit multiple pathways in chronic spontaneous urticaria (CSU). Objective: We sought to evaluate tezepelumab efficacy...
7.
Bernstein J, Cheng J, Pisani T, Sexton D, Whitaker R, Nova Estepan D, et al.
J Allergy Clin Immunol Glob . 2025 Feb; 4(2):100401. PMID: 39944300
Background: Functional C1 inhibitor (fC1INH) is a key biomarker for the diagnosis of hereditary angioedema due to C1 inhibitor (C1INH) deficiency. A novel fC1INH assay from dried blood spot (DBS)...
8.
Zielen S, Bernstein J, Sturm G, Jutel M, Pfaar O, Shamji M, et al.
Allergy . 2025 Feb; PMID: 39905623
Background: PQ Grass 27600 SU (PQ Grass) cumulative dose is a pre-seasonal, six-injection, aluminium-free, modified subcutaneous immunotherapy product under development for the treatment of allergic rhinitis (AR). A pivotal Phase...
9.
Munoz M, Schoepke N, Altrichter S, Staubach P, Geppert-Steidl C, Durner L, et al.
Clin Transl Allergy . 2025 Jan; 15(2):e70038. PMID: 39891034
Background: Symptomatic Dermographism (SD), also known as "urticaria factitia", is the most common subtype of chronic inducible urticaria. Affected patients develop itch and strip-shaped wheals that usually last for 30 ...
10.
Gimenez-Arnau A, Balp M, Danyliv A, Winders T, ODonoghue J, Kleebach J, et al.
Patient . 2025 Jan; 18(2):173-185. PMID: 39873902
Background: In the context of injectable biologic products approved or in development for chronic spontaneous urticaria (CSU), it is important to capture which treatment attributes matter most to patient and...